Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ranibizumab, Atc S01La04 (Obo) For The Period 01.09.2024 - 31.08.2026

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 18915757

  Document Type - Tender Notices

Description - Description: Section 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of the statutory health insurance compani es. In view of the relevant legal provisions for the award of public contracts, a regular process of active substance-related, formal award procedures takes place through DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active substance, Ranibizumab, ATC S01LA04, which are to be specified by the bidder in Annex 2 to the contract, DAK-Gesundheit intends to conclude drug discount agree

Gt Ref Id - 18915757

Deadline - Jul 05, 2026